6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Organoids and Lab-Grown Organs
Miniaturized biological systems capable of mimicking complex organ architecture are transforming regenerative medicine. Organoids and lab-grown organs offer powerful platforms for modeling disease, studying development, and exploring therapeutic interventions without relying on animal models. Derived from stem cells and grown in three-dimensional culture systems, organoids self-organize into structures resembling the functional units of organs like the liver, intestine, brain, or kidneys. Coupled with bioreactors and advanced scaffolds, lab-grown organs are progressing toward clinical relevance, especially in transplantation and toxicity testing. Organoids and lab-grown organs bridge developmental biology with engineering, opening new frontiers for personalized treatment, functional organ replacement, and ethical drug discovery that mirrors in vivo responses with remarkable fidelity.
Kunal Mitra
Florida Tech, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Paige Derr
National Institutes of Health, United States
Aradhana Kasimsetty
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Lisa Martin
University Grenoble Alpes, France
Audrey Cherblanc
Healshape SAS, FranceSubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States